INTERPACE BIOSCIENCES, INC. Income Statement
IDXG|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
INTERPACE BIOSCIENCES, INC. reported $39M in revenue and $25M in net income for FY2025. Revenue has declined at a 9.5% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.84 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38.7M | $46.9M | $20.7M | $5.7M | $8.2M | $32.4M | $24.2M | $21.9M | $15.9M | $13.1M | $9.4M | $119.9M | $146.5M | $126.9M | $157.3M |
| Cost of Revenue | $14.6M | $17.0M | $7.3M | $13.6M | $14.3M | $21.7M | $15.9M | $10.2M | $7.4M | $6.6M | $6.9M | $1.3M | - | - | - |
| Gross Profit | $24.1M | $29.9M | $13.4M | $18.2M | $18.8M | $10.7M | $8.3M | $11.7M | $8.5M | $6.4M | $2.5M | $206.0K | $23.5M | $26.9M | $32.5M |
| SG&A Expense | $9.5M | $9.5M | $5.4M | $11.0M | $10.7M | $18.2M | $14.4M | $8.5M | $9.2M | $10.5M | $16.9M | $14.3M | - | - | - |
| R&D Expense | $642.0K | $676.0K | $335.0K | $703.0K | $1.5M | $2.8M | $2.8M | $2.1M | $1.5M | $1.6M | $2.3M | $255.0K | - | - | - |
| Operating Income | $4.1M | $8.1M | $2.1M | -$3.6M | -$6.3M | -$26.1M | -$26.4M | -$12.1M | -$6.3M | -$6.4M | -$40.4M | -$17.8M | -$1.4M | -$25.2M | -$4.7M |
| Interest Expense | - | - | - | - | - | $549.0K | $440.0K | $331.0K | $433.0K | $2.1M | $3.7M | $602.0K | $0 | - | - |
| Income Tax | -$21.2M | $4.0K | $8.0K | $29.0K | -$705.0K | $53.0K | -$28.0K | $18.0K | -$395.0K | -$162.0K | -$13.1M | -$5.0M | $180.0K | $208.0K | -$939.0K |
| Net Income | $24.6M | $6.7M | $1.1M | -$22.0M | -$14.9M | -$26.5M | -$26.7M | -$3.2M | -$12.2M | -$8.3M | -$11.4M | -$16.1M | -$4.6M | -$25.5M | -$11.9M |
| EPS (Basic) | $1.42 | $0.25 | -$5.18 | -$3.61 | - | - | - | - | - | - | - | - | - | - | -$0.48 |
| EPS (Diluted) | $0.40 | $0.25 | -$5.18 | - | -$7.32 | -$7.25 | -$4.33 | -$0.77 | -$4.59 | -$7.34 | -$1.08 | -$0.31 | -$1.75 | -$0.83 | -$0.48 |
| Shares Outstanding | 4.4M | 4.3M | 4.3M | 4.2M | 39.2M | 39.2M | 2.9M | 27.8M | 2.2M | 1.8M | 15.4M | 15.2M | 15.0M | 14.7M | 14.4M |
| Gross Margin | 62.3% | 63.8% | 64.5% | 321.1% | 229.4% | 33.1% | 34.4% | 53.4% | 53.7% | 49.3% | 26.7% | 0.2% | 16.0% | 21.2% | 20.6% |
| Operating Margin | 10.5% | 17.3% | 9.9% | -63.7% | -77.3% | -80.5% | -109.1% | -55.4% | -39.6% | -49.2% | -428.4% | -14.9% | -1.0% | -19.9% | -3.0% |
| Profit Margin | 63.5% | 14.3% | 5.2% | -386.7% | -182.3% | -81.6% | -110.4% | -14.6% | -76.8% | -63.7% | -120.4% | -13.4% | -3.1% | -20.1% | -7.6% |